Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.

proudly announces that its highly anticipated oral Semaglutide weight loss treatment marketed and branded under the name ...

Securing a prescription for GLP-1s can be pricey — and not to mention, sometimes quite frustrating and invasive. But safety ...

Jon Gosselin dropped more than 50 lbs after starting semaglutide injections, but once he ran out of the weight-loss shots due ...

To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...

A study from tirzepatide's manufacturer found that the GLP-1 drug could significantly improve heart failure symptoms.

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

Semaglutide, a drug used for diabetes and weight loss, might help reduce opioid overdoses in people with OUD and T2D.

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

The results of Novo Nordisk’s phase 1 trials shows the oral weight loss pill could be more effective than semaglutide.

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...